The Successful Experiment
July 18, 2018
Sitting Down With… Mike Thompson, Chief Executive, Association of the British Pharmaceutical Industry (ABPI), UK.
1 min read
July 2018
Welcome to the July issue. Upfront investigates a new approach to making cancer drugs cheaper – with a paper ‘coffee’ filter; and a new report suggesting trust in pharma is nosediving. Tommy Fanning argues that Ireland’s biopharma sector will continue to thrive in light of US tax cuts and Brexit, in “In My View”, while our cover feature examines the future of the Chinese pharmaceutical industry, and what Made in China 2025 might mean for the rest of the world. Our second feature provides hard data, expert insight, and thoughts for the future of biopharma in the first of our three part series on Biopharma Trends. We also Sit Down With Mike Thompson, Chief Executive, Association of the British Pharmaceutical Industry (ABPI), UK.
It’s a Vendor’s Life: Lessons Learned with Rick Morris
July 18, 2018
Despite initially envisioning a career in the polymer and textiles industry, Rick Morris now builds equipment for biopharma manufacturers – and he loves it.
1 min read
At the Immuno-Oncology Frontier
July 18, 2018
The use of the body’s own immune system to fight cancer – immuno-oncology – has seen great progress over the last decade, with a number of big pharma companies working to further advance the field in the next ten years. Here, we learn more from Bryan (Bo) Barnhart, Senior Director of Immuno-Oncology at Bristol-Myers Squibb.
1 min read
Maintaining the Analytical Edge
July 18, 2018
Working across life sciences, performance materials and healthcare divisions, Site Management Analytics is Merck’s internal solutions provider for tough analytical challenges. Here, we learn more from Christoph Saal, Director, Site-Management Analytics Healthcare, and Saskia Haehn, Manager, E&L and Packaging Materials.
1 min read
All Eyes on Biopharma Trends
July 18, 2018
What are the hot topics in biopharma manufacture? What are the challenges? And where do we need to go? We provide hard data, expert insight, and thoughts for the future in a three part series. Here, we present Part 1.
1 min read
Make China Great Again
July 18, 2018
China is on course to reclaim its historical position as the world’s largest economy by 2050. But the Chinese government, not satisfied with this trajectory, wants to modernize its economy and occupy the highest parts of global production chains – including pharma – much sooner. Will “Made in China 2025” succeed? We speak with industry insiders, consultants and academics to find out where The Red Dragon is headed – and what non-Chinese pharma companies need to know.
1 min read
Faster, Cheaper, Better
July 18, 2018
Are catalysts being fully exploited in small molecule drug manufacture to reduce costs and boost process speed?
1 min read
The End of “Mini-Me” Medicine
July 18, 2018
Pediatric drug formulation has historically lagged behind the adult counterpart. Have government regulations had the right impact?
1 min read
Ireland’s Brexit Trump Card
July 18, 2018
Despite the Trump administration’s tax cuts coming into force and Brexit on the horizon, Ireland’s biopharmaceutical sector will continue to thrive.
1 min read
In Pharma We (Don’t) Trust
July 18, 2018
Consumer trust in pharma nosedives because of the “blame game”
1 min read
Pure and Simple(r)
July 18, 2018
Making cancer drugs cheaper and more effective – with a paper “coffee” filter
1 min read
A Nice Outsourcing View
July 18, 2018
What is the current state of pharma contract development and manufacturing?
1 min read
There’s Something in the Water
July 18, 2018
Drug emissions in UK rivers raise questions about long-term consequences for the environment
1 min read
